Cargando…

In Vivo Selectivity and Localization of Reactive Oxygen Species (ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum Resistance

[Image: see text] Platinum drugs are widely used for cancer treatment. Other precious metals are promising, but their clinical progress depends on achieving different mechanisms of action to overcome Pt-resistance. Here, we evaluate 13 organo-Os complexes: 16-electron sulfonyl-diamine catalysts [(η(...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coverdale, James P. C., Bridgewater, Hannah E., Song, Ji-Inn, Smith, Nichola A., Barry, Nicolas P. E., Bagley, Ian, Sadler, Peter J., Romero-Canelón, Isolda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2018
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204601/ https://www.ncbi.nlm.nih.gov/pubmed/30230827 http://dx.doi.org/10.1021/acs.jmedchem.8b00958

Ejemplares similares

In‐Cell Activation of Organo‐Osmium(II) Anticancer Complexes
por: Needham, Russell J., et al.
Publicado: (2016)

NMR studies of group 8 metallodrugs: (187)Os-enriched organo-osmium half-sandwich anticancer complex
por: Needham, Russell J., et al.
Publicado: (2021)

Targeting cancer lactate metabolism with synergistic combinations of synthetic catalysts and monocarboxylate transporter inhibitors
por: Bridgewater, Hannah E., et al.
Publicado: (2023)

Half-Sandwich Arene Ruthenium(II) and Osmium(II) Thiosemicarbazone Complexes: Solution Behavior and Antiproliferative Activity
por: Gatti, Anna, et al.
Publicado: (2018)

Osmium–arene complexes with high potency towards Mycobacterium tuberculosis
por: Coverdale, James P C, et al.
Publicado: (2021)

Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation
por: Romero-Canelón, Isolda, et al.
Publicado: (2015)

Tracking Reactions of Asymmetric Organo‐Osmium Transfer Hydrogenation Catalysts in Cancer Cells
por: Bolitho, Elizabeth M., et al.
Publicado: (2021)

Synchrotron X‐Ray Fluorescence Nanoprobe Reveals Target Sites for Organo‐Osmium Complex in Human Ovarian Cancer Cells
por: Sanchez‐Cano, Carlos, et al.
Publicado: (2017)

Mitochondria-targeted spin-labelled luminescent iridium anticancer complexes
por: Venkatesh, V., et al.
Publicado: (2017)

Transfer hydrogenation catalysis in cells as a new approach to anticancer drug design
por: Soldevila-Barreda, Joan J., et al.
Publicado: (2015)

Photoactivatable Cell-Selective Dinuclear trans-Diazidoplatinum(IV) Anticancer Prodrugs
por: Shi, Huayun, et al.
Publicado: (2018)

Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing C(∧)N-Chelated and Pyridine Ligands
por: Liu, Zhe, et al.
Publicado: (2014)

The Potent Oxidant Anticancer Activity of Organoiridium Catalysts**
por: Liu, Zhe, et al.
Publicado: (2014)

Easy To Synthesize, Robust Organo‐osmium Asymmetric Transfer Hydrogenation Catalysts
por: Coverdale, James P. C., et al.
Publicado: (2015)

Organoruthenium Complexes with Benzo-Fused Pyrithiones Overcome Platinum Resistance in Ovarian Cancer Cells
por: Kladnik, Jerneja, et al.
Publicado: (2021)

Contrasting Anticancer Activity of Half-Sandwich Iridium(III) Complexes Bearing Functionally Diverse 2-Phenylpyridine Ligands
por: Millett, Adam J., et al.
Publicado: (2015)

Organometallic Iridium(III) Anticancer Complexes with New Mechanisms of Action: NCI-60 Screening, Mitochondrial Targeting, and Apoptosis
por: Hearn, Jessica M., et al.
Publicado: (2013)

Correction to Organometallic Iridium(III) Anticancer Complexes with New Mechanisms of Action: NCI-60 Screening, Mitochondrial Targeting, and Apoptosis
por: Hearn, Jessica M., et al.
Publicado: (2013)

Transfer Hydrogenation and Antiproliferative Activity of Tethered Half-Sandwich Organoruthenium Catalysts
por: Chen, Feng, et al.
Publicado: (2018)

Platinum(iv)-azido monocarboxylato complexes are photocytotoxic under irradiation with visible light
por: Shaili, Evyenia, et al.
Publicado: (2021)

Ligand-centred redox activation of inert organoiridium anticancer catalysts
por: Zhang, Wen-Ying, et al.
Publicado: (2020)

Mirror-Image Organometallic Osmium Arene Iminopyridine Halido Complexes Exhibit Similar Potent Anticancer Activity
por: Fu, Ying, et al.
Publicado: (2013)

Strategies for conjugating iridium(III) anticancer complexes to targeting peptides via copper-free click chemistry
por: Zhang, Wen-Ying, et al.
Publicado: (2019)

Osmium Arene Germyl, Stannyl, Germanate, and Stannate Complexes as Anticancer Agents
por: Nabiyeva, Tomiris, et al.
Publicado: (2021)

Dose- and time-dependent tolerability and efficacy of organo-osmium complex FY26 and its tissue pharmacokinetics in hepatocarcinoma-bearing mice
por: Kumar, Swati A, et al.
Publicado: (2020)

New activation mechanism for half-sandwich organometallic anticancer complexes
por: Banerjee, Samya, et al.
Publicado: (2018)

Halide Control of N,N-Coordination versus N,C-Cyclometalation and Stereospecific Phenyl Ring Deuteration of Osmium(II) p-Cymene Phenylazobenzothiazole Complexes
por: Needham, Russell J., et al.
Publicado: (2017)

Photoactivatable platinum anticancer complex can generate tryptophan radicals
por: Vallotto, Claudio, et al.
Publicado: (2018)

Vapor Pressures of Ruthenium and Osmium
por: Carrera, N. J., et al.
Publicado: (1964)

Axial functionalisation of photoactive diazido platinum(iv) anticancer complexes
por: Shi, Huayun, et al.
Publicado: (2020)

Osmium Atoms and Os(2) Molecules Move Faster on Selenium-Doped Compared to Sulfur-Doped Boronic Graphenic Surfaces
por: Barry, Nicolas P. E., et al.
Publicado: (2015)

Single-Cell Chemistry of Photoactivatable Platinum Anticancer Complexes
por: Bolitho, Elizabeth M., et al.
Publicado: (2021)

Sequence-dependent attack on peptides by photoactivated platinum anticancer complexes
por: Wootton, Christopher A., et al.
Publicado: (2018)

Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer
por: Qi, Ruogu, et al.
Publicado: (2017)

Circumventing the Greatwall
por: Short, Ben
Publicado: (2014)

A novel Osmium-based compound targets the mitochondria and triggers ROS-dependent apoptosis in colon carcinoma
por: Maillet, A, et al.
Publicado: (2013)

Serum-binding properties of isosteric ruthenium and osmium anticancer agents elucidated by SEC–ICP–MS
por: Klose, Matthias H. M., et al.
Publicado: (2018)

Anticancer osmium complex inhibitors of the HIF-1α and p300 protein-protein interaction
por: Yang, Chao, et al.
Publicado: (2017)

Designing malaria vaccines to circumvent antigen variability()
por: Ouattara, Amed, et al.
Publicado: (2015)

Osmium: An Appraisal of Environmental Exposure
por: Smith, Ivan C., et al.
Publicado: (1974)

Cannot write session to /tmp/vufind_sessions/sess_esc0jpfikrfk6ag039c77da471